An Umbrella Review of Effectiveness of Intravenous Ketamine in Treatment-Resistant Depression
European Psychiatry April 1, 2024 A. M. Klassen, C.t.m. Baten, J. H. Shepherd et al.
Repeated-dose intravenous ketamine is an effective rapid-acting treatment for treatment-resistant depression. In a large-scale analysis of 1,182 participants across 51 primary studies, intravenous ketamine produced statistically significant reductions in depression symptoms compared to placebo and other control conditions, as measured by standardized clinician and self-report scales. The findings provide quantitative support for ketamine's effectiveness in treatment-resistant depression and highlight variations in treatment parameters across the literature.